奥昔卡因结构式
|
常用名 | 奥昔卡因 | 英文名 | Oxethazaine |
---|---|---|---|---|
CAS号 | 126-27-2 | 分子量 | 467.643 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 630.4±55.0 °C at 760 mmHg | |
分子式 | C28H41N3O3 | 熔点 | 104-105°C | |
MSDS | 中文版 美版 | 闪点 | 335.1±31.5 °C | |
符号 |
GHS07 |
信号词 | Warning |
奥昔卡因用途Oxethazaine是一种局部麻醉剂,在防止酸诱导的食管疼痛。 |
中文名 | 奥昔卡因 |
---|---|
英文名 | Oxethazaine |
中文别名 | 2-双(N-甲基-N-苯基叔丁基-氨基甲酰甲基)氨基乙醇 | 阿塞赛因 |
英文别名 | 更多 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 630.4±55.0 °C at 760 mmHg |
熔点 | 104-105°C |
分子式 | C28H41N3O3 |
分子量 | 467.643 |
闪点 | 335.1±31.5 °C |
精确质量 | 467.314789 |
PSA | 64.09000 |
LogP | 4.94 |
外观性状 | 白色粉末 |
蒸汽压 | 0.0±1.9 mmHg at 25°C |
折射率 | 1.558 |
储存条件 | 2-8℃ |
水溶解性 | <0.1 g/100 mL at 23 ºC |
分子结构 | 1、 摩尔折射率:137.83 2、 摩尔体积(cm3/mol):427.6 3、 等张比容(90.2K):1107.1 4、 表面张力(dyne/cm):44.9 5、 极化率(10-24cm3):54.64 |
计算化学 | 1.疏水参数计算参考值(XlogP):3.8 2.氢键供体数量:1 3.氢键受体数量:4 4.可旋转化学键数量:12 5.互变异构体数量:无 6.拓扑分子极性表面积64.1 7.重原子数量:34 8.表面电荷:0 9.复杂度:585 10.同位素原子数量:0 11.确定原子立构中心数量:0 12.不确定原子立构中心数量:0 13.确定化学键立构中心数量:0 14.不确定化学键立构中心数量:0 15.共价键单元数量:1 |
更多 | 1.熔点(℃):104-105。 |
符号 |
GHS07 |
---|---|
信号词 | Warning |
危害声明 | H302 |
个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
危害码 (欧洲) | Xn: Harmful; |
风险声明 (欧洲) | R22 |
安全声明 (欧洲) | S36 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
RTECS号 | AC3325000 |
~% 奥昔卡因 126-27-2 |
文献:Journal of Organic Chemistry, , vol. 26, p. 2378 - 2383 |
~% 奥昔卡因 126-27-2 |
文献:Journal of Organic Chemistry, , vol. 26, p. 2378 - 2383 |
~% 奥昔卡因 126-27-2 |
文献:US2780646 , ; |
奥昔卡因上游产品 4 | |
---|---|
奥昔卡因下游产品 0 |
Oxethazaine as the source of mephentermine and phentermine in athlete's urine
Forensic Sci. Int. 185(1-3) , e1-5, (2009) The urine specimens of numerous athletes were found to be positive for mephentermine both in-competition and out-of-competition in Taiwan. The donor of one specimen claimed she had only taken Mucaine ... |
|
Confirming urinary excretion of mephentermine and phentermine following the ingestion of oxethazaine by gas chromatography-mass spectrometry analysis.
J. Anal. Toxicol. 34(2) , 73-7, (2010) Mephentermine and phentermine, substances prohibited in sports by the World Anti-Doping Agency, were found for the first time in urine specimens following the administration of a therapeutic medicatio... |
|
A double-blind controlled study to compare the efficacy of an antacid plus oxethazaine with that of an antacid alone in the treatment of pain due to gastric or duodenal ulceration.
Curr. Med. Res. Opin. 10(2) , 128-34, (1986) A double-blind study was carried out in 40 patients with typical ulcer pain and suffering from gastric or duodenal ulcer to compare the pain-relieving efficacy of oxethazaine/magnesium and aluminium h... |
2,2'-[(2-Hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenyl-2-propanyl)acetamide] |
2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methylacetamide] |
Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl- |
N,N-Bis[N-methyl-N-phenyl-tert-butylacetamido]-b-hydroxyethylamine |
EINECS 204-780-5 |
2,2'-[(2-Hydroxyethyl)imino]bis[N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide] |
MFCD00079202 |
2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide |
oxethazine |
2,2'-[(2-Hydroxyethyl)imino]bis[N(1,1-dimethyl-2-phenylethyl)-N-methylacetamide] |